These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30364098)

  • 1. Inhibitory Effect of Japanese Traditional Kampo Formula Frequently Prescribed in Gynecological Clinics on CYP3A4.
    Ni H; Matsumoto T; Watanabe J; Makino T
    Evid Based Complement Alternat Med; 2018; 2018():4259603. PubMed ID: 30364098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1.
    Iijima R; Watanabe T; Ishiuchi K; Matsumoto T; Watanabe J; Makino T
    J Ethnopharmacol; 2018 Mar; 214():153-159. PubMed ID: 29248449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does a kampo medicine containing schisandra fruit affect pharmacokinetics of nifedipine like grapefruit juice?
    Makino T; Mizuno F; Mizukami H
    Biol Pharm Bull; 2006 Oct; 29(10):2065-9. PubMed ID: 17015952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standardization of Crude Drugs for the Japanese Pharmacopoeia].
    Hakamatsuka T
    Yakugaku Zasshi; 2020; 140(6):783-788. PubMed ID: 32475928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription of Kampo Formulations for Pre-natal and Post-partum Women in Japan: Data From an Administrative Health Database.
    Suzuki S; Obara T; Ishikawa T; Noda A; Matsuzaki F; Arita R; Ohsawa M; Mano N; Kikuchi A; Takayama S; Ishii T
    Front Nutr; 2021; 8():762895. PubMed ID: 34869533
    [No Abstract]   [Full Text] [Related]  

  • 6. Furanocoumarin derivatives in Kampo extract medicines inhibit cytochrome P450 3A4 and P-glycoprotein.
    Iwanaga K; Hayashi M; Hamahata Y; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
    Drug Metab Dispos; 2010 Aug; 38(8):1286-94. PubMed ID: 20463004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibitory effects of Kampo medicines on metabolic reactions catalyzed by human liver microsomes.
    Takahashi K; Uejima E; Morisaki T; Takahashi K; Kurokawa N; Azuma J
    J Clin Pharm Ther; 2003 Aug; 28(4):319-27. PubMed ID: 12911685
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kakimoto M; Nomura T; Nazmul T; Kitagawa H; Kanno K; Ogawa-Ochiai K; Ohge H; Ito M; Sakaguchi T
    Front Pharmacol; 2022; 13():804103. PubMed ID: 35422704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.
    Veronese ML; Gillen LP; Burke JP; Dorval EP; Hauck WW; Pequignot E; Waldman SA; Greenberg HE
    J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of herbal medicines in Japan.
    Saito H
    Pharmacol Res; 2000 May; 41(5):515-9. PubMed ID: 10753549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of furanocoumarins in Kampo extract-based medicines on rat intestinal absorption of CYP3A and P-glycoprotein substrate drugs in vivo.
    Iwanaga K; Arimune K; Miyazaki M; Shibano M; Taniguchi M; Baba K; Kakemi M
    Arch Pharm Res; 2012 Jun; 35(6):1055-64. PubMed ID: 22870815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological considerations of Kampo medicines in clinical use.
    Ikegami F; Fujii Y; Satoh T
    Toxicology; 2004 May; 198(1-3):221-8. PubMed ID: 15138045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances.
    Terauchi M; Hiramitsu S; Akiyoshi M; Owa Y; Kato K; Obayashi S; Matsushima E; Kubota T
    Arch Gynecol Obstet; 2011 Oct; 284(4):913-21. PubMed ID: 21120510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cheminformatics modeling of the correlation between Bupleurum Root-formula medicines and Excess and Deficiency pattern in the diagnostic criteria of Sho in Kampo (traditional Japanese medicine) by non-targeted direct infusion mass spectrometry with machine learning.
    Okada T; Namiki T; Tohge T; Kanaya S
    J Nat Med; 2022 Jan; 76(1):306-313. PubMed ID: 34661849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of traditional herbal medicinal products in Japan.
    Maegawa H; Nakamura T; Saito K
    J Ethnopharmacol; 2014 Dec; 158 Pt B():511-5. PubMed ID: 25043783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK).
    Saito M; Hirata-Koizumi M; Miyake S; Hasegawa R
    Eur J Clin Pharmacol; 2005 Aug; 61(7):531-6. PubMed ID: 16041596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of grapefruit juice in relation to human pharmacokinetic study.
    Uno T; Yasui-Furukori N
    Curr Clin Pharmacol; 2006 May; 1(2):157-61. PubMed ID: 18666368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Japanese Kampo formulas by analyzing database of medical records: a preliminary observational study.
    Yoshino T; Katayama K; Horiba Y; Munakata K; Yamaguchi R; Imoto S; Miyano S; Mima H; Watanabe K
    BMC Med Inform Decis Mak; 2016 Sep; 16(1):118. PubMed ID: 27619018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient Prescriptions of Kampo Formulations in Japan.
    Yamana H; Ono S; Michihata N; Jo T; Yasunaga H
    Intern Med; 2020 Nov; 59(22):2863-2869. PubMed ID: 32713918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Kampo medicines on P-glycoprotein.
    Satoh T; Watanabe Y; Ikarashi N; Ito K; Sugiyama K
    Biol Pharm Bull; 2009 Dec; 32(12):2018-21. PubMed ID: 19952421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.